Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Soft-Tissue Sarcomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Early research (Phase 1)Study completedNCT03454451
What this trial is testing

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

Who this might be right for
Non-Small Cell Lung CancerRenal Cell CancerColorectal Cancer+10 more
Corvus Pharmaceuticals, Inc. 117
Testing effectiveness (Phase 2)Looking for participantsNCT05726383
What this trial is testing

Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma

Who this might be right for
Osteogenic Sarcoma Recurrent
Hackensack Meridian Health 32
Early research (Phase 1)Ended earlyNCT02408861
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmAnal CarcinomaHIV Infection+7 more
National Cancer Institute (NCI) 79
Early research (Phase 1)Study completedNCT03126591
What this trial is testing

Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eli Lilly and Company 41
Large-scale testing (Phase 3)Ended earlyNCT02929394
What this trial is testing

Trabectedin Maintenance Post 1st-line in STS

Who this might be right for
Sarcoma, Soft Tissue
European Organisation for Research and Treatment of Cancer - EORTC 13
Not applicableEnded earlyNCT02720796
What this trial is testing

Patient-Derived Xenograft (PDX) Modeling in Adult Patients With Metastatic or Recurrent Sarcoma

Who this might be right for
Sarcoma
Champions Oncology 17
Early research (Phase 1)Ended earlyNCT04900766
What this trial is testing

Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Bone and Soft Tissue Sarcoma

Who this might be right for
Unresectable or Metastatic Bone and Soft Tissue Sarcoma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 31
Early research (Phase 1)Looking for participantsNCT07633756
What this trial is testing

A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy

Who this might be right for
Phase 1bOpen LabelREC-617+2 more
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Testing effectiveness (Phase 2)Study completedNCT01391962
What this trial is testing

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

Who this might be right for
Sarcoma, Alveolar Soft Part
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT02978859
What this trial is testing

Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas

Who this might be right for
LiposarcomaMetastatic Liposarcoma
Columbia University 29
Early research (Phase 1)Ended earlyNCT01341496
What this trial is testing

Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal

Who this might be right for
SarcomaMelanomaEpithelial Malignancies+1 more
National Cancer Institute (NCI) 41
Not applicableStudy completedNCT00003793
What this trial is testing

Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma

Who this might be right for
LeukemiaMyelodysplastic SyndromesSarcoma
Children's Oncology Group 294
Large-scale testing (Phase 3)Looking for participantsNCT03016819
What this trial is testing

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

Who this might be right for
Alveolar Soft Part SarcomaLeiomyosarcomaSynovial Sarcoma+1 more
Advenchen Laboratories, LLC 325
Early research (Phase 1)UnknownNCT04032964
What this trial is testing

Dose Finding Study of L19TNF and Doxorubicin in Patients With STS

Who this might be right for
Soft Tissue Sarcoma
Philogen S.p.A. 2
Large-scale testing (Phase 3)Active Not RecruitingNCT04994132
What this trial is testing

Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma

Who this might be right for
Alveolar RhabdomyosarcomaBotryoid-Type Embryonal RhabdomyosarcomaEmbryonal Rhabdomyosarcoma+5 more
Children's Oncology Group 113
Large-scale testing (Phase 3)Study completedNCT00782145
What this trial is testing

A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
Tufts Medical Center 198
Not applicableLooking for participantsNCT07642375
What this trial is testing

Study of the Impact of Digital Health Interventions on Symptom & Side-Effect Management in Metastatic Sarcoma Patients

Who this might be right for
Advanced SarcomaMetastatic Sarcoma
CareAcross 108
Not applicableStudy completedNCT00003801
What this trial is testing

Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma

Who this might be right for
Long-term Effects Secondary to Cancer Therapy in ChildrenSarcoma
National Cancer Institute (NCI)
Next Page